CVE-2023-37412
CVE-2023-37412 is a medium-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 4.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-250.
Key facts
- Severity: Medium (CVSS 3.x base score 4.4)
- EPSS exploit prediction: 0% (19th percentile)
- Actively exploited: Not listed in CISA KEV
- EU (EUVD) id: EUVD-2023-41313
- Weakness: CWE-250
- Affected product: Ibm Aspera Faspex
- Published:
- Last modified:
Description
IBM Aspera Faspex 5.0.0 through 5.0.10 could allow a privileged user to make system changes without proper access controls.
Frequently asked questions
- What is CVE-2023-37412?
- IBM Aspera Faspex 5.0.0 through 5.0.10 could allow a privileged user to make system changes without proper access controls.
- How severe is CVE-2023-37412?
- CVE-2023-37412 has a CVSS 3.x base score of 4.4, rated medium severity. It is exploitable over network with high attack complexity, requires high privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.
- Is CVE-2023-37412 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (19th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-37412?
- CVE-2023-37412 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-37412?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- Does CVE-2023-37412 have an EU (EUVD) identifier?
- Yes. CVE-2023-37412 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-41313.
- When was CVE-2023-37412 published?
- CVE-2023-37412 was published on 2025-01-29 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*
More vulnerabilities in Ibm Aspera Faspex
- CVE-2023-27874 — Critical (CVSS 9.9): IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A…
- CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
- CVE-2026-14959 — Critical (CVSS 9.1): IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 could allow a remote authenticated attacker to execute arbitrary code due to…
- CVE-2026-14958 — Critical (CVSS 9.1): IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 could allow a remote authenticated attacker to execute arbitrary code due to…
- CVE-2026-14996 — High (CVSS 8.2): IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 has addressed a vulnerability related to session management.
- CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…
All CVEs affecting Ibm Aspera Faspex →
Other CWE-250 vulnerabilities
- CVE-2026-4606 — Critical (CVSS 10.0): GV Edge Recording Manager (ERM) v2.3.1 improperly runs application components with SYSTEM-level privileges, allowing…
- CVE-2022-2634 — Critical (CVSS 10.0): An attacker may be able to execute malicious actions due to the lack of device access protections and device…
- CVE-2026-70496 — Critical (CVSS 9.9): A flaw was found in search-v2-operator. The operator's ClusterRole has permissions equivalent to a cluster…
- CVE-2026-72508 — Critical (CVSS 9.9): A flaw was found in the multicloud-operators-subscription component of Red Hat Advanced Cluster Management (RHACM).…
- CVE-2026-48584 — Critical (CVSS 9.9): Execution with unnecessary privileges in Azure Synapse allows an authorized attacker to elevate privileges over a…
- CVE-2026-50566 — Critical (CVSS 9.9): Fission is an open-source, Kubernetes-native serverless framework that simplifies the deployment of functions and…